Citigroup Raises Astera PT to $275, Maintains Buy Rating

Citigroup Raises Astera PT to $275, Maintains Buy Rating

Citigroup has raised its price target for Astera Labs (NASDAQ:ALAB) to $275, while maintaining a Buy rating for the stock. This move comes on the heels of Astera Labs' impressive second-quarter results, which saw the company report a non-GAAP diluted earnings per share of $0.44, far exceeding the forecasted $0.11, and record revenue of $191.9 million, a 150% increase compared to the same period last year Astera Labs stock hits all-time high of 237.9 USD^[2].

The company's strong performance has been driven by robust growth in its revenue and gross profit margin, which reached 75.5% during the quarter. Additionally, Astera Labs has seen its stock surge by an impressive 399.22% over the last 12 months, reflecting strong investor confidence and business growth Astera Labs stock hits all-time high of 237.9 USD^[2].

Citigroup's analysts highlighted Astera Labs' ability to navigate supply chain challenges, particularly with Taiwan Semiconductor Manufacturing Company's advanced nodes, and its focus on expanding its product offerings and market presence. These factors have contributed to the company's record-breaking achievement, with its stock hitting an all-time high of $237.9 USD in August 2025 Astera Labs stock hits all-time high of 237.9 USD^[2].

The positive outlook for Astera Labs is further supported by the company's strong balance sheet and profitability on a GAAP basis. Moreover, institutional investors, including GSG Advisors LLC, Alliancebernstein L.P., and Atreides Management LP, have significantly increased their holdings in the company's stock, underscoring the market's confidence in Astera Labs' growth trajectory GSG Advisors LLC Boosts Position in Astera Labs, Inc. $ALAB^[3].

Astera Labs' stock has shown resilience, opening at $238.79 on Wednesday, September 12, 2025, after a 3.2% increase the previous day. The company's 52-week low is $44.40, and its 52-week high is $241.29. The firm's market capitalization stands at $39.69 billion, with a PE ratio of 426.41 and a P/E/G ratio of 5.87 GSG Advisors LLC Boosts Position in Astera Labs, Inc. $ALAB^[3].

In conclusion, Citigroup's price target increase for Astera Labs reflects the company's strong performance and promising growth prospects. The stock's recent gains and positive analyst ratings suggest that investors remain optimistic about Astera Labs' future potential.